Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary  Syndrome Patients?

Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary Syndrome Patients?

November 3, 2015 at 9:14 AM 0 comments

This symposium took place on 14th September 2015 as part of the 51st Annual Meeting of the European Association for the Study of Diabetes (EASD) in Stockholm, Sweden Chairperson: Ele Ferrannini1 Speakers: Ele Ferrannini,1 Stephen J Nicholls,2 Jørgen Rungby,3 Jean-Claude Tardif,4 Faiez Zannad5 1. University of Pisa School of Medicine,Read More

Why Are Incretin-Based Therapies More Efficient in East Asians? Perspectives from the Pathophysiology of Type 2 Diabetes and East Asian Dietary Habits

Why Are Incretin-Based Therapies More Efficient in East Asians? Perspectives from the Pathophysiology of Type 2 Diabetes and East Asian Dietary Habits

November 3, 2015 at 9:12 AM 0 comments

*Daisuke Yabe,1,2,3,4 Hitoshi Kuwata,1 Masahiro Iwasaki,2,4 Yutaka Seino1 1. Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka, Japan 2. Center for Metabolism and Clinical Nutrition, Kansai Electric Power Hospital, Osaka, Japan 3. Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Osaka, JapanRead More

Benefits of Bariatric Surgery and Perioperative Surgical Safety

Benefits of Bariatric Surgery and Perioperative Surgical Safety

November 3, 2015 at 9:11 AM 0 comments

Ji Chung Tham,1 *Carel W. le Roux2,3 1. General and Vascular Surgery Department, Musgrove Park Hospital, Taunton, UK 2. Diabetes Complications Research Centre, UCD Conway Institute, School of Medicine and Medical Science, University College Dublin, Dublin, Ireland 3. Gastrosurgical Laboratory, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden *Correspondence to carel.leroux@ucd.ieRead More

Moderate Hypoxia Exposure: A Novel Strategy to Improve Glucose Metabolism in Humans?

Moderate Hypoxia Exposure: A Novel Strategy to Improve Glucose Metabolism in Humans?

November 3, 2015 at 9:08 AM 0 comments

Max Vogel, Ellen Blaak, *Gijs Goossens Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, Netherlands *Correspondence to G.Goossens@maastrichtuniversity.nl Disclosure: The authors have declared no conflicts of interest. Received: 22.07.15 Accepted: 03.09.15 Citation: EMJ Diabet. 2015;3[1]:73-79. Abstract The obesity epidemic callsRead More

The Concept of Early Vascular Ageing –  An Update in 2015

The Concept of Early Vascular Ageing – An Update in 2015

November 3, 2015 at 9:06 AM 0 comments

*Peter M. Nilsson Lund University, Malmö, Sweden *Correspondence to peter.nilsson@med.lu.se Disclosure: The author has declared no conflicts of interest. Received: 05.01.15 Accepted: 13.03.15 Citation: EMJ Diabet. 2015;3[1]:80-86. Abstract Arterial ageing is a process that can be quantified, at least to some degree, by measurement of pulse wave velocity along theRead More

REST/NRSF Target Genes in Neuronal and Beta Cells: Pathophysiological and Therapeutic Perspectives for Diabetes and Neurodegenerative Disorders

REST/NRSF Target Genes in Neuronal and Beta Cells: Pathophysiological and Therapeutic Perspectives for Diabetes and Neurodegenerative Disorders

November 3, 2015 at 9:04 AM 0 comments

*Amar Abderrahmani Lille University, CNRS, CHU Lille, Institut Pasteur de Lille, Lille, France *Correspondence to amar.abderrahmani@univ-lille2.fr Disclosure: The author has declared no conflicts of interest. Received: 30.06.15 Accepted: 30.07.15 Citation: EMJ Diabet. 2015;3[1]:87-95. Abstract Pancreatic beta and neuronal cells share numerous similarities, including a key transcriptional mechanism of the differentiationRead More

Transforming Growth Factor Beta-Based Therapies, a Potential Modulator of the Immune Response in Type 1 Diabetes?

Transforming Growth Factor Beta-Based Therapies, a Potential Modulator of the Immune Response in Type 1 Diabetes?

November 3, 2015 at 9:01 AM 0 comments

*E. Allison Green Centre for Immunology and Infection, Hull York Medical School and Department of Biology, University of York, York, UK *Correspondence to allison.green@york.ac.uk Disclosure: The author has declared no potential conflicts of interest. Received: 31.07.15 Accepted: 17.09.15 Citation: EMJ Diabet. 2015;3[1]:96-102. Abstract Immunobiological interventions are proving to be anRead More

Investigating the Different Dimensions of DPP-4 Inhibitors

Investigating the Different Dimensions of DPP-4 Inhibitors

October 31, 2014 at 9:58 AM 0 comments

Summary of Presentations from the Takeda Pharmaceuticals International-Sponsored Symposium, held at the 50th Annual Meeting of the EASD, Vienna, Austria, on 15th September 2014 Chairperson: Heinz Drexel1 Speakers: Jørgen Rungby,2 Jochen Seufert,3 Kausik Ray4 1. Department of Medicine, Academic Teaching Hospital Feldkirch, Feldkirch, Austria; Private University in the Principality ofRead More

Diffusion Tensor Imaging Of the Brain in Type 1 Diabetes

Diffusion Tensor Imaging Of the Brain in Type 1 Diabetes

October 31, 2014 at 9:51 AM 0 comments

Jo Ann V. Antenor-Dorsey,a Joshua S. Shimony,b *Tamara Hersheya-c Psychiatry,a Radiology,b and Neurologyc Departments, Washington University School of Medicine, St. Louis, Missouri, USA *Correspondence to tammy@wustl.edu Disclosure: No potential conflict of interest. Received: 07.03.14 Accepted: 30.07.14 Citation: EMJ Diabet. 2014;2:42-47. Abstract Individuals with Type 1 diabetes mellitus (T1DM) are requiredRead More

Detection and Early Lifestyle Intervention in Those at Risk of Type 2 Diabetes

Detection and Early Lifestyle Intervention in Those at Risk of Type 2 Diabetes

October 31, 2014 at 9:39 AM 0 comments

Charlotte L. Edwardson,1 Laura J. Gray,2 Thomas Yates,1 Shaun R. Barber,2 Kamlesh Khunti,1 *Melanie J. Davies1 1. Diabetes Research Centre, University of Leicester, Leicester, UK 2. Department of Health Sciences, University of Leicester, Leicester, UK *Correspondence to melanie.davies@uhl-tr.nhs.uk Disclosure: No potential conflict of interest. Received: 21.03.14 Accepted: 21.07.14 Citation: EMJRead More